Edinburgh, UK, 4th January 2017 / Synpromics Ltd, the leading synthetic promoter and gene control company, is pleased to announce a research collaboration with GE Healthcare to jointly develop customised synthetic promoters optimised for GE Healthcare’s proprietary biopharmaceutical manufacturing platform. Synpromics will […]
The post Synpromics announces a research collaboration with GE Healthcare to Extend the Toolbox for Production of Biologics appeared first on SynBioBeta.